Stockscreener 앱 받기
16.81
2.55%
-0.44
시간 외 거래:
16.81
전일 마감가:
$17.25
열려 있는:
$17.26
하루 거래량:
1.18M
Relative Volume:
0.93
시가총액:
$1.55B
수익:
$2.98B
순이익/손실:
$-300.00M
주가수익비율:
-4.9441
EPS:
-3.4
순현금흐름:
$225.00M
1주 성능:
-3.39%
1개월 성능:
+31.84%
6개월 성능:
+225.15%
1년 성능:
-9.87%
1일 변동 폭
$16.20
$17.27
1주일 범위
$16.20
$17.69
52주 변동 폭
$3.97
$20.26
Fortrea Holdings Inc Stock (FTRE) Company Profile
명칭
Fortrea Holdings Inc
전화
877-495-0816
주소
8 MOORE DRIVE, DURHAM
FTRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
16.81 | 1.59B | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-08-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-05-02 | 개시 | Truist | Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-07-24 | 재개 | Barclays | Equal Weight |
| 2024-06-06 | 개시 | Goldman | Neutral |
| 2024-05-29 | 개시 | TD Cowen | Hold |
| 2024-05-28 | 개시 | Mizuho | Neutral |
| 2024-03-22 | 개시 | Robert W. Baird | Neutral |
| 2024-03-06 | 개시 | Deutsche Bank | Hold |
| 2024-01-05 | 개시 | William Blair | Mkt Perform |
| 2024-01-04 | 개시 | Jefferies | Buy |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-12-01 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-11-14 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-19 | 개시 | Citigroup | Neutral |
| 2023-09-14 | 개시 | Evercore ISI | In-line |
| 2023-08-16 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 개시 | BofA Securities | Underperform |
모두보기
Fortrea Holdings Inc 주식(FTRE)의 최신 뉴스
Fortrea (NASDAQ:FTRE) Shares Down 5.6%Should You Sell? - MarketBeat
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Fortrea Holdings Inc. $FTRE Shares Sold by Voya Investment Management LLC - MarketBeat
Retail Trends: Why Fortrea Holdings Inc. stock is trending among retail tradersMarket Sentiment Report & Smart Investment Allocation Insights - moha.gov.vn
Squarepoint Ops LLC Decreases Stake in Fortrea Holdings Inc. $FTRE - MarketBeat
Behavioral Patterns of FTRE and Institutional Flows - Stock Traders Daily
What drives Fortrea Holdings Inc K67 stock priceMarket Entry Points & Exceptional Return Growth - earlytimes.in
Assenagon Asset Management S.A. Lowers Stock Position in Fortrea Holdings Inc. $FTRE - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Viridian Therapeutics (VRDN), Fortrea Holdings Inc. (FTRE) and Cytokinetics (CYTK) - The Globe and Mail
Fortrea Holdings (FTRE) price target increased by 18.02% to 13.36 - MSN
Can Fortrea Holdings Inc. stock maintain growth trajectoryWeekly Profit Recap & Daily Price Action Insights - Улправда
Why Fortrea Holdings Inc. stock remains on buy listsJuly 2025 Volume & Weekly High Return Stock Forecasts - Улправда
Will Fortrea Holdings Inc. stock see PE expansionProduct Launch & AI Based Buy and Sell Signals - Улправда
Why Fortrea Holdings Inc. (K67) stock appeals to dividend investorsWeekly Trading Summary & Daily Volume Surge Signals - Улправда
Why Fortrea Holdings Inc. stock is trending among retail tradersQuarterly Market Summary & Proven Capital Preservation Tips - Улправда
Death Cross: Can Fortrea Holdings Inc. stock maintain growth trajectoryJuly 2025 Weekly Recap & Daily Momentum Trading Reports - Улправда
Layoff Watch: Can Fortrea Holdings Inc. stock continue upward trendJuly 2025 Movers & AI Powered Trade Plan Recommendations - Улправда
Fortrea (FTRE) Stock Up 8% After Mizuho Raises Price TargetNews and Statistics - IndexBox
Why Fortrea (FTRE) Stock Is Up Today - Finviz
Is Fortrea Holdings Inc. stock a safe haven assetQuarterly Portfolio Report & Verified Entry Point Signals - Улправда
Fortrea (FTRE): Reassessing Valuation After a Sharp 3-Month Share Price Rebound - Yahoo Finance
Smart Money: Why Fortrea Holdings Inc. stock is in analyst buy zoneForecast Cut & Community Shared Stock Ideas - ulpravda.ru
Published on: 2025-12-19 16:51:02 - Улправда
Can Fortrea Holdings Inc. stock continue upward trendGlobal Markets & Real-Time Stock Price Movement Reports - Улправда
Why retail investors favor Fortrea Holdings Inc. stockWeekly Trade Report & Smart Investment Allocation Insights - Улправда
Why Fortrea Holdings Inc. stock is in analyst buy zoneWeekly Trade Analysis & Consistent Return Investment Signals - Улправда
Jana Partners adds Markel Group, exits Fortrea - MSN
Will Fortrea Holdings Inc. stock deliver better than expected guidance - Улправда
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Shareholders to Reach Out - ACCESS Newswire
Fortrea (FTRE) Stock Update: Analyst Price Target Increase to $13.00News and Statistics - IndexBox
Why Fortrea (FTRE) Stock Is Trading Up Today - Finviz
Fortrea (NASDAQ:FTRE) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Fortrea Holdings Inc. (FTRE) and Novan (NOVN) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Fortrea (FTRE) Partnership With SCTbio: Is the Rebound Justified by Its Current Valuation? - Sahm
Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire
Fortrea (NASDAQ:FTRE) Stock Rating Upgraded by Barclays - MarketBeat
Fortrea Holdings Shares Higher After Barclays Upgrade - marketscreener.com
Barclays Upgrades Fortrea Holdings (FTRE) - Nasdaq
FTRE: Barclays Upgrades Fortrea Holdings, Boosts Price Target by 50% | FTRE Stock News - GuruFocus
Barclays Upgrades Fortrea to Equal Weight From Underweight, Adjusts PT to $15 From $10 - marketscreener.com
Barclays upgrades Fortrea stock rating to Equalweight on biotech recovery By Investing.com - Investing.com UK
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Liquidity Mapping Around (FTRE) Price Events - news.stocktradersdaily.com
Beck Mack & Oliver LLC Sells 916,179 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. ... - Bakersfield.com
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.
Fortrea (NASDAQ:FTRE) Shares Gap UpHere's What Happened - MarketBeat
1,029,700 Shares in Fortrea Holdings Inc. $FTRE Acquired by Bank of Nova Scotia - MarketBeat
Does Fortrea (FTRE) Pairing With SCTbio And Citigroup’s Upgrade Reveal A Deeper Strategic Shift? - Sahm
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Fortrea Holdings Inc (FTRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.57%
자본화:
|
볼륨(24시간):